Amarin Corporation PLC (AMRN) is currently on a roll as the company is gearing up for the expanded market launch of its potential blockbuster drug Vascepa, which is now the only drug approved in the United States for lowering the risk of cardiovascular events in conjunction with statin therapy. It is estimated that the drug may touch the peak sales volume of $3-4 billion a year. However, after certain developments in the market, some analysts are thinking that the drug may be able to garner even higher revenue.
While Vascepa received its product label expansion in December, further increasing its market reach, the drug was given another positive fillip recently as competitor AstraZeneca (AZN) reported shelving trials for its Epanova drug candidate. The decision is not only going to cost the company to the tune of $100 million in write-offs but has also opened up a wider market for Amarin's Vascepa. Epanova was being touted as a strong rival to Vascepa and was expected to be a major player in the fish oil drug market. With Epanova out of the scene, Vascepa does not have any significant competition in the market.
Epanova is for treating high TG levels in adult patients suffering from hypertriglyceridemia. Had the company been successful with its now-abandoned STRENGTH study, it would have been able to market the drug to a wider market with label expansion.
Similarly, Amarin received another positive push as Acasti Pharma Inc. (ACST) also posted negative developments regarding its CaPre drug candidate. The company reported that a phase 3 trial of the drug failed to meet its endpoint, which was of the reduction of triglycerides by 20% in comparison to placebo. The trial showed that the median triglyceride reduction in patients taking CaPre was 30.5% and the corresponding reduction in the placebo arm was 27.5 percent. Thus, the drug failed to make a significant reduction in TG levels, leading to the failure of the trial.
Acasti is currently looking into the reasons behind the failure and has held unexpectedly strong placebo effect to be a major factor. It will audit patient records and raw data from its five targeted locations for further analysis. While the results of the investigation will be out by next month, Amarin is still likely to remain a forerunner.
Following these positive news, CEO John Thero said at JPM2020 that Amarin has been approached by a number of companies to license the drug in Europe. Vascepa is currently awaiting approval for its launch in Europe. Apparently, Amarin believes that it will be in a better position to bargain as the approval process further proceeds in Europe.
Amarin stock has performed erratically in the market in the past one year. The stock price has been through lots of ups and downs and now is expected to show positive traction in the market. However, there are certain caveats that need to be kept in mind by potential investors. While the company now has few direct competitors in the market, it still has to fend itself against potential generics. This impediment will be particularly significant if its ongoing patent lawsuit does not end up favorably. The company is currently embroiled in a legal battle with multiple pharma companies including Dr. Reddy's Laboratories and Hikma Pharmaceuticals.
On the positive side, the company is poised to boost its revenue and recently announced that it plans to double its sales personnel to touch 800 employees. Amarin now expects its 2020 sales volume to be in the range of $600-700 million. With court decision expected in near future, Amarin stock is looking ahead to plenty of action.
Arena Pharmaceuticals (ARNA) received positive news as the company reported its lead drug candidate APD418 receiving Fast Track review from the FDA. The treatment is being developed for decompensated heart failure which denotes a sudden deterioration in various symptoms such as difficulty in breathing, fatigue, and swelling in the legs and feet.
APD418 is a 3-adrenergic receptor (AdrR) antagonist and cardiac myotrope. It aims to improve cardiac contractility without causing adverse impact on blood pressure, heart rate, and myocardial oxygen consumption connected to inotrope therapies.
Fast Track status by the FDA comes with several advantages such as more frequent interaction with the FDA review team. It also provides the benefit of rolling review of the marketing application. Chris Cabell, MD, MHS, FACC, Arena's Senior Vice President and Chief Medical Officer said, "With approximately 10 million DHF patient hospital visits expected in the US by 2025 and few viable treatment options, we believe that APD418 has the potential to make a significant impact for these patients."
Arena Pharmaceuticals focuses on developing pharmacology and pharmacokinetics based medicines. Apart from APD418, it has APD811, APD334, and APD371 in the pipeline.
Home healthcare service provider LHC Group (LHCG) received a setback as Spruce Point Management released a bearish report about its prospects. According to the report, the healthcare service provider may face a 40 to 60 percent downside risk with regard to its stock price. The report makes extensive use of financial analysis and forensic accounting. The downside is mainly on account of the company's 2018 merger with Almost Family, which seems to be underperforming expectations. It was estimated that the business will grow 5 to 6 percent per year. The report also found management to be reluctant to share updates regarding its Almost Family business.
The report further elucidates upon other concerning factors such as management selectively divesting underperforming locations to artificially inflate organic growth figures. The company also excluded Almost Family numbers from organic sales, leading to organic growth inflation by nearly 500 bps. The report notes that the bad debt allowance allocated to Almost Family has been gradually inflated from $27 million to $65 million.
LHC Group stock has grown over 40 percent in the past 12 months and, currently, is trading close to its highs.
Thanks for reading. At the Total Pharma Tracker, we do more than follow biotech news. Using our IOMachine, our team of analysts work to be ahead of the curve.
That means that when the catalyst comes that will make or break a stock, we've positioned ourselves for success. And we share that positioning and all the analysis behind it with our members.
Disclosure: I am/we are long AMRN, ACST. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
See more here:
Amarin's Multiple Positives And Other News: The Good, Bad, And Ugly Of Biopharma - Seeking Alpha
- Cardiology and Cardiac Pharmacology [Last Updated On: April 4th, 2018] [Originally Added On: April 4th, 2018]
- EMS Pharmacology: Drugs That Affect the Cardiovascular System ... [Last Updated On: April 8th, 2018] [Originally Added On: April 8th, 2018]
- EMS Pharmacology: Drugs That Affect the Cardiovascular ... [Last Updated On: April 11th, 2018] [Originally Added On: April 11th, 2018]
- Cardiology Conferences - Cardiology and Cardiovascular ... [Last Updated On: June 5th, 2018] [Originally Added On: June 5th, 2018]
- Cardiovascular Pharmacology: Open Access - Open Access ... [Last Updated On: June 21st, 2018] [Originally Added On: June 21st, 2018]
- CV Pharmacology | Welcome to Cardiovascular Pharmacology ... [Last Updated On: July 31st, 2018] [Originally Added On: July 31st, 2018]
- Cardiology Conferences | Cardiac pharmacology 2018 ... [Last Updated On: September 13th, 2018] [Originally Added On: September 13th, 2018]
- Cardiology Conference | Cardiac Pharmacology 2019 ... [Last Updated On: November 18th, 2018] [Originally Added On: November 18th, 2018]
- Cardiovascular Pharmacology Online Course | Lecturio [Last Updated On: November 30th, 2018] [Originally Added On: November 30th, 2018]
- Cardiovascular Pharmacology: Open Access [Last Updated On: December 16th, 2018] [Originally Added On: December 16th, 2018]
- Cardiovascular In vivo Models for Drug Discovery [Last Updated On: December 21st, 2018] [Originally Added On: December 21st, 2018]
- UTHSC College of Medicine: Department of Pharmacology [Last Updated On: February 2nd, 2019] [Originally Added On: February 2nd, 2019]
- Department of Pharmacology - School of Medicine - LSU ... [Last Updated On: April 5th, 2019] [Originally Added On: April 5th, 2019]
- Cardiovascular Pharmacology: Open Access - longdom.org [Last Updated On: April 22nd, 2019] [Originally Added On: April 22nd, 2019]
- ASPET | Cardiovascular Pharmacology [Last Updated On: September 14th, 2019] [Originally Added On: September 14th, 2019]
- Pharmacogenomics Market (PGx) Competitive Research And Precise Outlook 2019 To 2025: Astrazeneca, GeneDX, Illumina, Inc., Laboratory Corporation of... [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Global and Chinese Microbiome Drugs Market: Industry strategic plan for the period 2019-2024 - Market Report Gazette [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Pharmacokinetics Market To Increase at Steady Growth Rate - Commerce Gazette [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944) - BioSpace [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Janssen to Highlight Depth of Prostate Cancer and Solid Tumor Portfolios with Multiple Data Presentations at ESMO 2019 - Yahoo Finance [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Cardiac fibrosis study identifies key proteins that translate into heart disease - BSA bureau [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Nitric Oxide: Worldwide Therapeutics & Markets to 2028 with Profiles on 35 Companies & 18 Collaborations Tabulated - Yahoo Finance [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23 Annual Scientific Meeting - Yahoo Finance [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Is it risky to continue with blood thinner drugs after a gastrointestinal bleed? - Medical News Bulletin [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Women urged to exercise and eat well due to cholesterol after menopause - Sydney Morning Herald [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert - Yahoo Finance [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Yale alumna Dr. Nancy Brown named dean of Yale School of Medicine - Yale News [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer - Business Wire [Last Updated On: October 7th, 2019] [Originally Added On: October 7th, 2019]
- G-Protein Coupled Receptors (GPCRs) Market Size And Prediction By Leading Manufacturers According To Its Application And Types Till 2022 - Space... [Last Updated On: October 7th, 2019] [Originally Added On: October 7th, 2019]
- Best supplements for blood pressure: The natural remedy proven to lower your reading - Express [Last Updated On: October 7th, 2019] [Originally Added On: October 7th, 2019]
- Advanced Drug Delivery Systems Market Growth Analysis 2019 to Share Key Aspects of the Industry with the details of Influence Factors Forecast to 2024... [Last Updated On: October 28th, 2019] [Originally Added On: October 28th, 2019]
- The 9 Biggest Technology Trends That Will Transform Medicine And Healthcare In 2020 - Forbes [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Potential PF Therapy AD-214 to Move into Phase 1 Testing in Humans - Pulmonary Fibrosis News [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT - Yahoo Finance [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- The Montreal Heart Institute celebrates its 500th heart transplant - GlobeNewswire [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Latest Research Report to uncover key Factors of Global Cardiovascular Repair And Reconstruction Devices Market - Market Research Base [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Global Cardiovascular Repair And Reconstruction Devices Market: Development History, Current Analysis and Estimated Forecast to 2025 - Market Research... [Last Updated On: November 29th, 2019] [Originally Added On: November 29th, 2019]
- The cardiac safety services market is projected to reach USD 752 million by 2024 from USD 442 million in 2019, at a CAGR of 11.2% - Yahoo Finance [Last Updated On: December 11th, 2019] [Originally Added On: December 11th, 2019]
- Evaluation of the Effect of Fish Oil Alone and in Combination with a P | DMSO - Dove Medical Press [Last Updated On: January 13th, 2020] [Originally Added On: January 13th, 2020]
- Heres What We Know About CBDs Effects On Varicose Veins - The Fresh Toast [Last Updated On: January 28th, 2020] [Originally Added On: January 28th, 2020]
- Hypertension: This Spice Can Help You Control High Blood Pressure Easily And Effectively - Doctor NDTV [Last Updated On: January 28th, 2020] [Originally Added On: January 28th, 2020]
- Cannabis Manual: Better Together - Weekly Alibi [Last Updated On: January 30th, 2020] [Originally Added On: January 30th, 2020]
- Pharmacology: Cardiovascular Drugs 1 (30 Items) - Nurseslabs [Last Updated On: March 1st, 2020] [Originally Added On: March 1st, 2020]
- A central master driver of psychosocial stress responses in the rat - Science Magazine [Last Updated On: March 9th, 2020] [Originally Added On: March 9th, 2020]
- The Global Cardiac Safety Services Market is expected to grow from USD 419.45 Million in 2018 to USD 865.23 Million by the end of 2025 at a Compound... [Last Updated On: March 29th, 2020] [Originally Added On: March 29th, 2020]
- Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment -... [Last Updated On: March 29th, 2020] [Originally Added On: March 29th, 2020]
- Fresh Produce In Short Supply? Prioritize This Veggie In Your Diet - mindbodygreen.com [Last Updated On: April 25th, 2020] [Originally Added On: April 25th, 2020]
- COVID-19: What's RNA research got to do with it? - University of Rochester [Last Updated On: May 1st, 2020] [Originally Added On: May 1st, 2020]
- What Happens When You Add Other Drugs To Your LSD Trip? - VICE [Last Updated On: May 1st, 2020] [Originally Added On: May 1st, 2020]
- Toward a Pharmacology of Resolution - Harvard Magazine [Last Updated On: May 1st, 2020] [Originally Added On: May 1st, 2020]
- GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com [Last Updated On: May 2nd, 2020] [Originally Added On: May 2nd, 2020]
- This Simple Breathing Advice From A Nobel Prize Winner Can Turn The Tables On Stress During The Coronavirus Lockdown - Forbes [Last Updated On: May 2nd, 2020] [Originally Added On: May 2nd, 2020]
- National Nurses Week 2020: What Experiences Have Shaped Your Nursing Career? - HealthLeaders Media [Last Updated On: May 2nd, 2020] [Originally Added On: May 2nd, 2020]
- Research Paper Stresses Importance of Repurposing Drugs Against COVID-19 - BioSpace [Last Updated On: May 13th, 2020] [Originally Added On: May 13th, 2020]
- Repurposing existing drugs to treat coronavirus will likely be quicker than a vaccine, scientists claim - CNBC [Last Updated On: May 13th, 2020] [Originally Added On: May 13th, 2020]
- Alzheimer's and Cannabis - Greenway - Greenway [Last Updated On: May 18th, 2020] [Originally Added On: May 18th, 2020]
- Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Third Annual Science Day - Business Wire [Last Updated On: June 2nd, 2020] [Originally Added On: June 2nd, 2020]
- Healthy people shouldn't take daily aspirin to prevent heart disease, review finds - WDJT [Last Updated On: June 6th, 2020] [Originally Added On: June 6th, 2020]
- Study reveals how living close to roadways may impact the brain - Drew Reports News [Last Updated On: June 18th, 2020] [Originally Added On: June 18th, 2020]
- Disruptions in circadian rhythms not only cause sleep disorders, but could also put you at risk of these... - Firstpost [Last Updated On: June 18th, 2020] [Originally Added On: June 18th, 2020]
- NeonMind Files Patent Application for Therapeutic Use of DMT - Yahoo Finance [Last Updated On: June 18th, 2020] [Originally Added On: June 18th, 2020]
- Vitamin D What you need to know about the sunshine vitamin - Medical News Bulletin [Last Updated On: July 9th, 2020] [Originally Added On: July 9th, 2020]
- Idorsia announces positive results in the second Phase 3 study of daridorexant - GlobeNewswire [Last Updated On: July 9th, 2020] [Originally Added On: July 9th, 2020]
- ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse - PRNewswire [Last Updated On: July 9th, 2020] [Originally Added On: July 9th, 2020]
- Drug Discovery Outsourcing Market Highly Favorable with new Demand to the Growth Rate by 2027| Thermo Fisher Scientific, Merck KGaA, Albany Molecular... [Last Updated On: August 21st, 2020] [Originally Added On: August 21st, 2020]
- Bringing Peer Review To Early COVID-19 Research, More News - Bio-IT World [Last Updated On: August 21st, 2020] [Originally Added On: August 21st, 2020]
- Cardiac Safety Services Market Research Report by Type of Service, by Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 -... [Last Updated On: August 21st, 2020] [Originally Added On: August 21st, 2020]
- UCI study finds women with diabetes and high levels of coronary artery calcium at greater risk of death than men - Newswise [Last Updated On: August 21st, 2020] [Originally Added On: August 21st, 2020]
- Globa Advanced Drug Delivery Systems Market 2020 Research, Key Players, Industry Overview, Supply and Consumption Analysis 2024 - Bulletin Line [Last Updated On: September 2nd, 2020] [Originally Added On: September 2nd, 2020]
- Esperion Announces Two Data Presentations of NEXLETOL (bempedoic acid) Tablet at the ESC Congress 2020 - GlobeNewswire [Last Updated On: September 2nd, 2020] [Originally Added On: September 2nd, 2020]
- Women with diabetes and high levels of coronary artery calcium at greater risk of death than men - UCI News [Last Updated On: September 2nd, 2020] [Originally Added On: September 2nd, 2020]
- 15 Clever Ways to Use Leftover Red Wine - Yahoo Lifestyle [Last Updated On: September 2nd, 2020] [Originally Added On: September 2nd, 2020]
- UK Study Leads to Better Understanding of Blood Pressure Regulation, Atherosclerosis - UKNow [Last Updated On: September 2nd, 2020] [Originally Added On: September 2nd, 2020]
- Academic always top of the class for pay and conditions - Extra.ie [Last Updated On: September 15th, 2020] [Originally Added On: September 15th, 2020]
- Cardiac Safety Services Market Size Is Rising Tremendously Due To Increasing Need of Healthcare Services Centralization Till 2025 - TC BizNews [Last Updated On: September 15th, 2020] [Originally Added On: September 15th, 2020]
- 5 Benefits of Berberine, Including Why It's a Healthy Gut All-Star - msnNOW [Last Updated On: September 15th, 2020] [Originally Added On: September 15th, 2020]
- Advanced Drug Delivery Systems Market 2020 Report Covers Key Growth Factors, Global Trends, Opportunities by Regions, Industry Size and Share... [Last Updated On: September 23rd, 2020] [Originally Added On: September 23rd, 2020]
- Janssen Presents Findings from Global, Multi-Center Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small... [Last Updated On: September 23rd, 2020] [Originally Added On: September 23rd, 2020]
- MASSIVE GROWTH OF DRUG DISCOVERY SERVICES MARKET WILL RAISE USD 19.1 BILLION BY 2027, CAGR +13% FROM 2020 TO 2027 WITH TOP KEY PLAYERS LIKE THERMO... [Last Updated On: September 29th, 2020] [Originally Added On: September 29th, 2020]
- The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% - Stockhouse [Last Updated On: September 29th, 2020] [Originally Added On: September 29th, 2020]